Tirzepatide is an FDA-approved dual GIP and GLP-1 receptor agonist, meaning it activates two hormone pathways at once for a more powerful effect on appetite and metabolism than single-receptor medications. It is prescribed and monitored by our medical team, and suitability is determined through a thorough assessment at your initial consultation.

While both are highly effective GLP-1 based medications, Tirzepatide also activates the GIP receptor, giving it a dual mechanism of action. Clinical trials have shown Tirzepatide produces greater average weight loss than Semaglutide, though the best option for you depends on your individual health profile, which our physicians assess at your consultation.

Yes. We are in-network with United Healthcare, Aetna, Cigna, Humana, and Anthem BCBS. Most medically supervised weight loss programs are covered. We currently cannot accept Medicare, Medicaid, Ambetter, or CareSource.

Absolutely. Virtual visits are available for patients throughout Cherokee County who prefer the convenience of remote care.

Results vary by individual, but many patients begin to notice meaningful changes within the first 4 to 8 weeks. Our team supports you with regular check-ins to keep you on track throughout your program.

In addition to Tirzepatide Weight Loss, we offer Semaglutide Weight Loss, Medical Weight Loss, Hormone Therapy for Men and Women, Menopause and Andropause Treatment, Bioidentical Hormone Therapy, Functional Medicine, Sexual Health services, and Aesthetics.